Endogenous tumour necrosis factor-α induction by interleukin-1α in nude mice transplanted with human glioma

International Journal of Immunotherapy

Volumn 12, Issue 3-4, 1996, Pages 33-47

  Tanaka, S ^a   Nishihara, T ^b   Nagashima, T ^b   Hori, T ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1ALPHA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOMA; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; TUMOR NECROSIS; TUMOR XENOGRAFT;

EID: 0030418377     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Nagai M Clinical trials of human fibroblast interferon (HulFN-β) on malignant brain tumors Nippon Gan Chiro Gakkai Shi, 18, 60, 1983 (in Japanese)
2. Nagai M, Arai T Clinical effect of interferon in malignant brain tumors. Neurosurg Rev., 7, 55, 1984.
3. Yoshida J. et al. Early phase II study of recombinant human tumor necrosis factor-α (PAC-4D) for malignant glioma. Jpn. Pharmacol Ther , 22 (Suppl). 291, 1994
4. Sugita K., Yoshida J Late phase II study of recombinant human tumor necrosis factor-α (PAC-4D) for malignant glioma. Jpn. Pharmacol. Ther , 22 (Suppl), 311, 1994.
5. Gresser I Antitumor effects of interferon. Adv. Cancer Res., 16, 97, 1972.
6. Carswell E A, Old L.J., Kassel R L , Green S , Fiore N , Williamson B An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl Acad Sci. USA, 72, 3666, 1975.
7. Decker T., Kohmann-Matthes M.L., Gifford G E. Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic mcrophages. J Immunol , 138, 957, 1987.
8. Nagai M., Arai T., Watanabe K Immunological state of patients with malignant glioma and its alteration by Interferon therapy Biotherapy (Tokyo), 2, 242, 1988.
9. Dinarello CA Interleukin-1 Rev. Infect. Dis , 6, 51, 1984.
10. Oppenheim J J., Kovacs E. J , Matsushima K , Durum S.K. There is more than one interleukin-1 Immunology Today, 7, 45, 1986.
11. Zsebo K M. et al Vascular endothelial cells and granulopoiesis Interleukin-1 stimulates release of G-CSF and GM-CSF. Blood, 71, 99, 1988.
12. Matsushima K , Onozaki K. Benczur M , Oppenheim J.J Studies of the production of interleukin 1 (IL-1) and potential antitumor activity of IL-1 In "The Physiologic, Metabolic, and Immunological Actions of Interleukin-1" Alan R Liss, New York, 1985, p. 253
13. Nakai S , Hirai Y. The therapeutic potential of interleukin-1β in the treatment of chemotherapy- or radiation-induced myelosuppression and in tumor therapy Biotherapy (Netherlands), 1, 339, 1989
14. Tanaka S. et al Preventive effects of interleukin-1β for chemotherapy-induced myelosuppression in malignant brain tumors The experimental and preliminary clinical Studies J. Neurooncol , 14, 159, 1992.
15. Tanaka S , NagashimaT., Manaka S , Hon T , Yasumoto S. Growth suppression and asuocytic differentiation of glioma cell lines by interleukin-1 J Neurosurg , 81, 402, 1994.
16. Nishida T et al cDNA cloning of IL-1α and IL-1β from mRNA of U937 cell line Biochem. Biophys. Res Commun . 143, 345, 1987
17. Sharkey F E , Fogh J Considerations in the use of nude mice for cancer research. Cancer Metastasis Rev , 3, 341, 1984
18. Shapiro W.R , Basler G.A , Chemik N.L., Posner J B Human brain tumor transplantation in nude mice. J. Natl Cancer Inst., 62, 447, 1979
19. Korosue K , Takeshita I , Mannoji H., Fukui M Interferon effects on multiplication, cytoplasmic protein and GFAP content. and morphology in human glioma cells. J. Neuro-Oncol , 1, 69, 1983
20. Nakamura S., Nakata K., Kashimoto S., Yoshida H , Yamada M Antitumor effect of recombinant human interleukin-1 alpha against murine syngeneic tumors Jpn. J. Cancer Res. (Gann), 77, 767, 1936.
21. Kido G , Wright J.L., Merchant R.E Acute effect of recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and an experimental glioma model J. Neurooncol , 10, 95, 1991
22. Del Maestro R F., Lopez-Torres M., McDonald W.B , Stroude E C., Vaithilingarn I.S The effect of tumor necrosis factor-α on human malignant glial cell. J. Neurosurg , 76, 652, 1992
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays J. Immunol., Meth , 65, 55, 1983
24. Sobotkova E , Nouza K Regulatory role of T lymphocytes and NK cells in tumor allograft development Neoplasma, 40, 75, 1993
25. Kawasaki E S. Amplification of RNA. In: Innis M A. et al (eds) "PCR Protocols, A Guide to Methods and Applications". Academic Press, San Diego, 1990, p. 21
26. Chomczynski P , Sacchi N. Single-step methods of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem , 162, 156, 1987.
27. Lansdorp P.M., Astaldi G.C.B , Oosterhof F., Janssen M.C , Zeijlemaker W P Immunoperoxidase procedures to detect monoclonal antibodies against cell surface antigens Quantitation of binding and staining of individual cells J Immunol Met., 39, 393, 1980
28. Suter L , Bruggen J , Sorg C Use of an enzyme-linked immunosorbent assay (ELISA) for screening of hybridoma antibodies against cell surface antigens J. Immunol Met , 39, 407, 1980
29. Onozaki K., Matsushima K , Aggarwall B B , Oppenheim J.J. Human interleukin-1 is a cytocidal factor for several tumor cell lines J Immunol , 135, 3962, 1985.
30. Beutler B , Cerami A. Cachectin More than a tumor necrosis factor Cancer Chemother Pharmacol., 20, 223, 1987
31. Fontana A , Hengartner H , Tribolet N., Weber E Glioblastoma cells release interleukin-1 and factors inhibitng interleukin-2-mediated effects J Immunol , 132, 1837, 1984
32. Nishida T , Nakai S., Kawakami T , Aihara K , Nishino N., Hirai Y Dexamethazone regulation of the expression of cytokine mRNAs induced by interleukin-1 in the astrocytoma cell line U-373MG FEBS Letters, 243, 25, 1989
33. Chung I.V., Benveniste E.N Tumor necrosis factor-α production by astrocytes: Induction by lipopolysaccriande. IFN-γ and IL-1β J. Immunol., 144, 3666, 1990.
34. Kobayashi Y , Sawada J., Osawa T Activation of membrane phospholipase-A by guinea pig lymphotoxin (GLT). J Immunol , 122, 791, 1979
35. Kull F C. Jr, Cuatrecasas P Possible requirement of internalization in the mechanism of in vitro cytotoxtcity in tumor necrosis serum Cancer Res , 41, 4885, 1981.
36. Kitamura T , Takaku F Pre-clinical and Phase I sludy IL-1β Jpn J Exp. Med , 7, 1838, 1989.